
Laboratory models provide an essential tool in helping to understand the cellular and molecular drivers of respiratory disease. Discoveries at the laboratory bench from examination of both human tissue and tissues from animal models have informed the life-saving technologies and clinical care used today. Yet, elucidating the driving factors and physiological explanations underpinning poor outcomes in preterm birth survivors is crucial to optimising clinical care and identifying therapeutic targets. This review highlights the clinical evidence underpinning an active respiratory disease process after preterm birth. Furthermore, it explores the benefits and drawbacks of existing models to research the long-term respiratory outcomes of preterm birth.
Like
Save
Share